This site uses cookies to ensure you get the best experience. Learn more

Sign up or log in to follow your favorite podcasts and listen to episodes!

Kristina M. Deligiannidis, MD - Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants

PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

Go online to to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in psychiatry discusses the use of GABA-modulating neuroactive steroids as rapid-acting antidepressants. Upon completion of this activity, participants should be better able to: Discuss the role of GABAergic dysfunction in PPD and MDD and the rationale for therapeutic targeting of GABA-A receptors with neuroactive steroids; Review the current treatment landscape and unmet needs of patients with MDD; Identify key barriers to the diagnosis and management of PPD; Apply recent evidence on the efficacy and safety of approved and emerging neuroactive steroids to the management of patients with PPD and MDD.

Disclaimer: the content and artwork of this podcast are the property of its owner and are not affiliated with nor endorsed by Audiotrails.